NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
about
Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?Emerging role of Toll-like receptor 4 in hepatocellular carcinomaRole of innate immunity in the development of hepatocellular carcinomaToll-like receptors in pathophysiology of liver diseasesPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesMolecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKInflammation- and stress-related signaling pathways in hepatocarcinogenesisToll-like receptor 2 and type 2 diabetes.Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese populationPeroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.IPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation.Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.Hepatic metabolism of retinoids and disease associationsToll-like receptor signaling in liver regeneration, fibrosis and carcinogenesisRole of Toll-like receptors in liver health and disease.Toll-like receptors and liver disease.The role of macrophages in obesity-driven chronic liver disease.Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.Alcoholic liver disease - Hepatocellular carcinoma transformation.Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.Perihepatic lymph node enlargement is a negative predictor of liver cancer development in chronic hepatitis C patients.A cis-acting regulatory variation of the estrogen receptor α (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis.miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling.Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
P2860
Q26770029-0DC3A7B2-3573-48C0-9788-B187B371EAECQ26824613-8A842C6E-BA1E-45CB-846F-08E0DAB5B0E2Q27024780-5E3AB6A2-A5C3-42DA-ABE0-FEA5939EB738Q28070077-90457CF5-A758-471D-98DB-2BED25EB80EDQ28272678-F26E0A7A-A9F3-43A5-9EDF-5E1081E3DF04Q28384866-DEE5805F-F9CE-49D3-A8F6-398150C45BBBQ28387669-889F56E3-038A-4794-840E-BCA195D5BD03Q33634951-2F9CC0D2-B2F7-467D-8CB3-C26368C10CA3Q34315221-14E2639B-FFE0-42E0-9795-0F0D360A5CC1Q34483561-DE906627-54E7-4F99-89FD-E6D24132D58DQ34873314-9FB400E9-77DB-4BE3-81A2-EC72AFBF12EFQ35832150-F066ED24-1BDA-4466-BC52-4A5A41A508C0Q36249804-5C1E3F50-A770-4AE8-A4EC-AB855B18B29DQ36368963-B5BEDA9D-1533-4184-9123-6DACF603C77DQ37125483-6DD7648E-2EC0-4C31-90EE-168B1869E0C2Q37907346-F038C425-54E4-4124-84BF-2829FCEB2802Q38151944-A20459E1-1D92-4A1F-AE85-A52EA2CF3DE8Q38758810-EFD10374-3EA3-49F7-B79A-78AE7AB95A7CQ39523106-A3B7F80B-F038-4309-BDC0-4FF854A26C9CQ40146321-4016DFAB-D061-41AB-8C02-F169B9FBF4C2Q42201909-CBD41AE0-B6B9-4A1F-8D0C-9D901F892F02Q42618642-9CD30DDD-1D12-46F4-9820-33C10670B769Q42982168-AEF081B7-09E9-4B24-B479-F498498315B5Q45364189-4FB88EC6-9180-417A-8207-EA34ACDCD724Q50932877-E3B8EBC9-B3EB-4A21-BB49-BE52931054FCQ51872814-A54C3337-88E0-4F55-A13A-1B90DED85833Q54197800-0D368BA9-2F41-44F5-9170-6F3045DDC215Q54596901-A6FD3B08-2186-4E58-BFAD-465FB1107766
P2860
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@ast
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@en
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@nl
type
label
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@ast
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@en
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@nl
prefLabel
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@ast
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@en
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@nl
P2860
P356
P1476
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
@en
P2093
Shin Maeda
P2860
P304
P356
10.1155/2010/367694
P407
P577
2010-01-01T00:00:00Z